Literature DB >> 21544896

Chondromyxoid fibroma of the nasal septum: case report and review of literature.

Stanley W McClurg1, Marino Leon, Theodoros N Teknos, O Hans Iwenofu.   

Abstract

BACKGROUND: Chondromyxoid fibroma (CMF) is a rare bone tumor, accounting for less than 0.5% of all bone tumors, with a predilection for lower extremity bone metaphyses. Involvement of the head and neck is extremely rare, with only 3 cases reported in the nasal septum in world literature.
METHODS: This is a case report of a CMF in the nasal septum of a 49-year-old woman with a 6-month history of congestion. MRI showed a bilobed mass originating from the nasal septum. Histologic and immunoperoxidase staining as well as electron microscopic studies were performed. A literature review was performed.
RESULTS: The patient underwent a midface-degloving approach for surgical resection. The final pathology was prototypic of CMF. The patient was disease-free 16 months postoperatively.
CONCLUSIONS: CMF is a rare, benign neoplasm occasionally occurring in the head and neck. Surgical resection is often curative. CMF must be differentiated from chondrosarcoma, given the substantial differences in treatment.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21544896     DOI: 10.1002/hed.21760

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  3 in total

Review 1.  Soft Tissue Special Issue: Chondroid Neoplasms of the Skull.

Authors:  A N Flaman; J K Wasserman; D H Gravel; B M Purgina
Journal:  Head Neck Pathol       Date:  2020-01-16

Review 2.  Chondromyxoid fibroma of the temporal bone: A rare case report.

Authors:  Tao Liu; Jing Yao; Xiaoyu Li; Xinmeng Qi; Pengyun Zhao; Zhiqiao Tan; Jie Wang; Yongxin Li
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

Review 3.  Sinonasal Chondromyxoid Fibroma: Case Report and Literature Review.

Authors:  Nadeem El-Kouri; Alhasan Elghouche; Shaoxiong Chen; Taha Shipchandler; Jonathan Ting
Journal:  Cureus       Date:  2019-10-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.